Refined adenoviral transduction for controlled gene transfer into human adult mesenchymal stem cells;Kontrollierter gentransfer in humane adulte mesenchymale stammzellen mittels adenoviraler vektoren

Zeitschrift fur Orthopadie und Ihre Grenzgebiete

Volumn 143, Issue 6, 2005, Pages 677-683

  Koch, Hannjörg ^a   Jadlowiec, J A ^b   Whalen, J D ^c   Lattermann, C ^d   Robbins, P ^e   Fu, F H ^d   Merk, H ^a   Hollinger, J O ^b  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b CARNEGIE MELLON UNIVERSITY   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Adenoviral transduction; BMP 2; Human mesenchymal stem cells; Osteoblastic differentiation; Quantitative real time PCR

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN TYPE 1; LUCIFERASE; TRANSCRIPTION FACTOR RUNX2;

ADENOVIRUS; ADULT; ANALYSIS OF VARIANCE; ARTICLE; CELL DEATH; CELL LINEAGE; CELL SURVIVAL; CONTROLLED STUDY; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; MARKER GENE; MESENCHYMAL STEM CELL; OSTEOBLAST; PHENOTYPE; POLYMERASE CHAIN REACTION; POST HOC ANALYSIS; PROTEIN CONTENT; TRANSGENE;

ADENOVIRIDAE; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; HUMANS; MESENCHYMAL STEM CELLS; OSTEOBLASTS; TISSUE ENGINEERING; TRANSDUCTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 29944432851     PISSN: 00443220     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-872526     Document Type: Article

References (27)

1. Cheng SL, Lou J, Wright NM, Lai CF, Avioli LV, Riew KD. In vitro and in vivo induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene. Calcif Tissue Int 2001; 68: 87-94
2. Lou J, Xu F, Merkel K, Manske P. Gene therapy: adenovirus-mediated human bone morphogenetic protein-2 gene transfer induces mesenchymal progenitor cell proliferation and differentiation in vitro and bone formation in vivo. J Orthop Res 1999; 17: 43-50
3. Partridge K, Yang X, Clarke NM, Okubo Y, Bessho K, Sebald W, Howdle SM, Shakesheff KM, Oreffo RO. Adenoviral BMP-2 gene transfer in mesenchymal stem cells: in vitro and in vivo bone formation on biodegradable polymer scaffolds. Biochem Biophys Res Commun 2002; 292: 144-152
4. Riew KD, Wright NM, Cheng S, Avioli LV, Lou J. Induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene in a rabbit spinal fusion model. Calcif Tissue Int 1998; 63: 357-360
5. Turgeman G, Pittman DD, Muller R, Kurkalli BG, Zhou S, Pelled G, Peyser A, Zilberman Y, Moutsatsos IK, Gazit D. Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapy. J Gene Med 2001; 3: 240-251
6. Smith P, Shuler FD, Georgescu HI, Ghivizzani SC, Johnstone B, Niyibizi C, Robbins PD, Evans CH. Genetic enhancement of matrix synthesis by articular chondrocytes: comparison of different growth factor genes in the presence and absence of interleukin-1. Arthritis Rheum 2000; 43: 1156-1164
7. Niyibizi C, Baltzer A, Lattermann C, Oyama M, Whalen JD, Robbins PD, Evans CH. Potential role for gene therapy in the enhancement of fracture healing. Clin Orthop 1998; 335 Suppl: S148-S153
8. Baltzer AW, Lattermann C, Whalen JD, Wooley P, Weiss K, Grimm M, Ghivizzani SC, Robbins PD, Evans CH. Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene. Gene Ther 2000; 7: 734-739
9. Peterson B, Iglesias R, Zhang J, Wang JC, Lieberman JR. Genetically modified human derived bone marrow cells for posterolateral lumbar spine fusion in athymic rats: beyond conventional autologous bone grafting. Spine 2005; 30: 283-289
10. Peterson B, Zhang J, Iglesias R, Kabo M, Hedrick M, Benhaim P, Lieberman JR. Healing of critically sized femoral defects, using genetically modified mesenchymal stem cells from human adipose tissue. Tissue Eng 2005; 11: 120-129
11. Sugiyama O, Orimo H, Suzuki S, Yamashita K, Ito H, Shimada T. Bone formation following transplantation of genetically modified primary bone marrow stromal cells. J Orthop Res 2003; 21: 630-637
12. Riew KD, Lou J, Wright NM, Cheng SL, Bae KT, Avioli LV. Thoracoscopic intradiscal spine fusion using a minimally invasive gene-therapy technique. J Bone Joint Surg [Am] 2003; 85: 866-871
13. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997; 276: 71-74
14. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147
15. Grove JE, Bruscia E, Krause DS. Plasticity of bone marrow-derived stem cells. Stem Cells 2004; 22: 487-500
16. Musgrave DS, Bosch P, Lee JY, Pelinkovic D, Ghivizzani SC, Whalen J, Niyibizi C, Huard J. Ex vivo gene therapy to produce bone using different cell types. Clin Orthop 2000; 378: 290-305
17. Niyibizi C, Smith P, Mi Z, Phillips CL, Robbins P. Transfer of pro-alpha2(I) cDNA into cells of a murine model of human Osteogenesis Imperfecta restores synthesis of type 1 collagen comprised of alpha1(1) and alpha2(1) heterotrimers in vitro and in vivo. J Cell Biochem 2001; 83: 84-91
18. AppliedBiosystems. User Bulletin #2: ABI Prism 7700 Sequence Detection System. AppliedBiosystems, Foster City, CA updated 10/2001
19. Lehrman S. Virus treatment questioned after gene therapy death. Nature 1999; 401: 517-518
20. Kaiser J. Gene therapy. Seeking the cause of induced leukemias in X-SCID trial. Science 2003; 299: 495
21. Check E. A tragic setback. Nature 2002; 420: 116-118
22. Van Damme A, Vanden Driessche T, Collen D, Chuah MK. Bone marrow stromal cells as targets for gene therapy. Curr Gene Ther 2002; 2: 195-209
23. Studeny M, Marini FC, Dembinski JL, Zompetta C, Cabreira-Hansen M, Bekele BN, Champlin RE, Andreeff M. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst 2004; 96: 1593-1603
24. Kurozumi K, Nakamura K, Tamiya T, Kawano Y, Ishii K, Kobune M, Hirai S, Uchida H, Sasaki K, Ito Y, Kato K, Honmou O, Houkin K, Date I, Hamada H. Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. Mol Ther 2005; 11: 96-104
25. Chang SC, Chuang HL, Chen YR, Chen JK, Chung HY, Lu YL, Lin HY, Tai CL, Lou J. Ex vivo gene therapy in autologous bone marrow stromal stem cells for tissue-engineered maxillofacial bone regeneration. Gene Ther 2003; 10: 2013-2019
26. Baltzer AW, Whalen JD, Stefanovic-Racic M, Ziran B, Robbins PD, Evans CH. Adenoviral transduction of human osteoblastic cell cultures: a new perspective for gene therapy of bone diseases. Acta Orthop Scand 1999; 70: 419-424
27. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997; 89: 747-754